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The mammahan GABAA receptor is a multisubunit protein containing a variety of bindinl~ ite~ for p~ychotmpic agents. One of the most widely 
used of these drugs, ethanol, enhances the function of GABAA receptors m certain circu,nstance~ but not others. Previous tudies have demonstrated 
that alternative ~plicing of the y2L GABA subunit results m an ethanol ~ensitive and an ethanol-insensitwe form, when combined with ct and fl 
~ubunits We have used m vitro mutagenesm and expression i  Xettoptt~ oocytes to show that the consensus .~lte for phosphorylation byprotein 
kina~e C contained mthe ?'2L insert m critical for modulation by ethanol but not benzodmzepmes, and mampulation f the phosphorylating enzymes 
in ooeytc~ conta,nmg 0clfll ?2L can prevent ethanol enhancement, it is likely that phosphorylation r dephosphorylation of a specific site on the 
GABA~ receptor protein can act a~ a control mechanism for neuronal respoll~es to alcohol exposure. 
GABAA receptor; Ethanol; Phosphol'ylation, Protein kmaso C; Mutagenesis 
1 INTRODUCTION 
The COABAA receptor is a member of the ligand-gated 
ion channel family and probably exists m a variety of 
different forms in distinct regions of the nervous ystem. 
The GABA receptor complex is made up from a combi- 
nation of = [1-6], ,8 [1-3] and T [1-3] subunits [1-9]. 
and p subunits have also been identified [10,11]. Alter- 
native splicing of subunits has added yet another layer 
of complexity to the possible forms of the GABA recep- 
tor [12-14] and the pharmacological consequences of
this phenomenon remain relatively unexplored. The 
GABA receptor complex contains binding sites for a 
number of therapeutically active drugs, including ben- 
zodiazepines, barbiturates and steroids. Alcohol also 
exerts at least some of its neurological effects by influ- 
encing the activity of the GABAA receptor. Historically 
ethanol was believed to act via its actions on biological 
membranes, however, recent studies uggest that its ef- 
fects are mediated by a more direct action on a number 
of different receptor proteins and ion channels; GABA, 
NMDA, voltage-sensitive calcium channels and 5HT3 
receptors are all influenced by intoxicating levels of al- 
cohol [15]. The sedating properties of ethanol are al- 
most certainly mediated via the GABA,x receptor and 
studies have demonstrated an enhancement of GABA 
function in a number of different systems [16-22]. This 
enhancement is not universal throughout the nervous 
system and some regions eem particularly sensitive .g. 
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cerebellum, whereas others e.g. hippocampus are rela- 
tively insensitive. Benzodiazepine potentiation of the 
GABA receptor is influenced by the presence of a 7"2 
subunit [2]. Ethanol potentiation is also dependent on 
the presence of a 7 subunit, but further to this requires 
a specific alternatively spliced version of the 7'2 subunit 
containing an extra eight amino acids in the region 
between M3 and M4, a proposed intracellular loop [23]. 
Interestingly this additional splice insert contains acon- 
sensus phosphorylation sequence for protein kinase C 
[12]. We have used in vitro mutagenesis techniques and 
manipulation of GABA receptor subunits expressed in 
Xenopus oocytes to explore the role of the consensus 
phosphorylation sequence in drug modulation of the 
GABA receptor complex. 
2. MATERIALS AND METHODS 
Frog~ were mahllalllgd illaquarium tanksat room temperature with 
a 1~1211 hght/dark cycle and fed a regular diet ofchopped steak and 
crieketb. To obtain oocytes, froga were anaesthelt~l with 0.5% tri- 
cauue and a small piece ofovar), was removed through an incision in 
the abdominal wall. Statue V and ¥I ooeytes were l.solated and the 
theca and epithelial cell layer were directed away with fine forcep~ 
Follicle cells were removed by an 8-nun treatment m Sigma Type IA 
collagena~e (0.5 mg/ml) dissolved in modified Barth's aline (MBS) 
(88 mM NaCI, 1 mM KCI, 10 mM HEPES, 0 82 mM MeSOn, 0 33 
mM Ca(NOd,, 0.91 mM CoOl:, 2.4 mM NaHCOs, pH 7.5). Ooeyte~ 
were rejected with 50 nl of a solution containing mixtures ofsubunlt 
eRNAs (1-2 mg/ml) ubln8 a 10 ttl mieropipette w~th an internal diam- 
eter of 20/~m. Oocytes were incubated in individual wells of a 24.well 
culture plate at 19"C for 2 days° m MBS supplemented with 2 mM 
sodium pyruvate, penicillin (100 U/ml), streptomycin ~100 mffmlJ anti 
gentamycin (50 mg/rnl). 
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Fig. 1 Typical examples of current.~ recorded in Xenopus oocyte~ 
expre~fin8 GABAA receptors, after ejection of mRNA [29] made up 
from combining the following subanits (a) ~ Ifll 2L, (b) ctlilt 7"2S and 
(c) 0:lfll~'2Ser. The effect of 20 mM ethanol on current responses to
30.aM GABA is shown for each combination asmdtcated by the bars 
over each trace, mid are typical of at leant ~x different cells from three 
.~eparate donor frogs. 
For recording, oocytes were placed m a 50/al bath and perfused with 
MBS at 10-13 ml/min. Cells were impaled with two 1-3 M electrodes 
containing 3 M KCI and voltage-clamped at -70 inV, Drugs were 
apphed m the perfusate and were preapplied for 30 s prior to exposure 
to GABA in combination with the dru~. GABA was applied until the 
respons~ reached a maximum, usually approximately 30s. 
The bovine r,l, fll,72L and 72S cDNAs have been described previ- 
ouqy [l,12,24]. cRNA was prepared from 0tl and fll ¢DNAs a~ prev.:- 
ously described, cRNA was prepared from }'2L eDNA (wild type and 
mutants) in Bluescript Sk- (Stratasene) by liaearization with Kpnl 
and transcription with T3 polymerase. S~t~-direeted mutagenesis was 
performed using the method of Kunkel et al. [25] using the oligonucle- 
otides 5'.AACCCTCTTC'VrCGOATGGCCCCTACAATTGACA- 
TCCG-3" (Z2L^4), 5'-GAAGAAAAACCCTC1"rCTTGCCCCTA. 
CATTGACATCCG.3' (g2L^6), 5'-CTTCGGATG'ITTGCCAAG. 
GCC-3' w2L~r~Aia) and 5"-GTTTTCCfffCC I'GOCCCC I'AC- 
AATrG-3' (72LLys~Lea). Single-stranded phagelnid DNA pre- 
pared from T2L eDNA in Bluescript Sk- was used as template. Mu- 
tant cDNAs were screcne¢l by sequencang of mdw~daal clones. 
3. RESULTS 
GABA,~ receptor subunit mRNAs  were made from 
the appropriate bovine cDNAs, and expressed in Xen- 
opus oocytes. The combinations of ~zl/5172L and 
alfll y2S, both had equivalent responses to GABA with 
a concentration of 30 ,aM elieiting approximately half- 
maximal amplitudes. The benzodiazepine flunitraze- 
pare potentiated the current elicited by 30 #M GABA 
with a maximal effect at a concentration of  I ktM. The 
extent of  potentiation was approximately 65% in both 
cases and there was no significant difference in the ex- 
tent of potentiation. Ethanol potentiated only receptors 
containing the y2L subunit (25.5 _+ 3.8% 0z = 19)) and 
had no effect on those containing the ~,2S subunit ( -6  
+_ 0.8% (n - 6)) (Figs. la,b and 2) or those consisting 
ofonly  cxl#l (-8.5 +_ 2% (n = 6)). As there are only eight 
extra amino acids in the 72L subunit, deletion mutants 
were made by selectively removing amitao ,tcids. GABA 
ECs0 was not affected by any of the mutations, and we 
used the same concentration of GABA to evaluate drug 
modulation. By removing either six or four amino acids 
we eliminated the potentiating effect of ethanol on the 
GABA response (Fig. 2). The eight amino acid insert 
contains a consensus ite for protein kinase C (Ser-X- 
Lys, [2@. To determine its role in ethanol potentiation 
we made point mutations to alter this consensus e- 
quence. Mutating Ser 343 to an alanine, which cannot be 
phosphorylated, or by changing Lys 34s (the C-terminal 
basic residue required for phosphorylation site consen- 
sus sequence), also abolished any ethanol potentiation 
(Fig. lc). Benzodiazepine potentiation was not affected 
by any of the above mutations in the ?'2L subunit, 
demonstrating a special role for the 8 amino acid insert, 
and specifically the protein kinase C consensus phos- 
phorylation site, for ethanol potentiation (Fig. 2). 
The data generated by mutagenesis uggested that 
phosphorylation by protein kinase C was important for 
the potentiation of  GABA receptors by ethanol. We 
attempted to show that this site was important in func- 
tional receptors containing the full 72L subunit by alter- 
ing the state of phosphorylation. We allowed the 
oocytes to express GABAA receptors lbr two days in 
normal supplemented MBS medium, incubated them 
overnight in a medium containing 0.2 mM of the pro- 
tein kinase inhibitor isoquinolinesulphonyl-2-methyl 
piperazine dihydrochloride (H-7), and then examined 
the potentiation of  GABA currents by flunitrazepam 
and ethanol. Flunitrazepam enhanced currents in both 
control and H-7 treated oocytes to the same extent. 
Ethanol, however, was unable to potentiate GABA cur- 
rents ofoocytes treated with H-7 (Fig. 3). Phorbol esters 
stimulate protein kinase C and have been shown to 
reduce GABAA currents in Xenopus oocytes [27,28]. 
After 20 rain treatment with l0 nM PMA the GABA 
response was inhibited by approximately 50%; however, 
the ethanol potentiation was unaffected (data not 
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Fig. 2. Expression of different comblnattons of GABAA ~ubuntts in Xenoptts oocytes aud modulation ofc.nrrent~ elicited by 30/aM GABA by 
20 mM ethanol and l/zM flumtrazepam respectively. ~xland ~1 sabunits were xpressed together with the 2" subunit variants listed in (a) which 
illustrates the eight amino acid insert of 72L m bold. The amino acM deletion mutants made are indicated ~'2^4 and 2'2"6, and the sire-directed 
mutants are shown to change the Set ~t~ to alanine (;.'2SeO and th~ Lys ~ to leucme (72Lys). (b) Modulation of all combinations tested by 20 mM 
ethanol and I/aM flunttmz=pam, As the ~1~1 combination had a ~lightly lower GABA ECho, 10/zM GABA was used. Each bar is the m~n ± 
S E.M. of s~x dtfl'erent observations onoocytes from at I~ast 3.~eparat¢ donor frogs. 
shown) suggesting that the protein kinase C site on the 
2,'2L insert is already fully phosphorylated. We also 
studied the effect of cAMP dependent kinase by co- 
expressing the fl.adrenergic receptor together with the 
GADA receptor. By activating the fl-adrenergic recep- 
tor with 100 aM isoproterenol which stimulates the 
cAMP dependent kinase or protein kinase A, again the 
GABA response was reduced, this time by 21 __. 2.7% 
but the ethanol potentiation was not affected~ with 
mean potentiation before exposure to isoproterenol f  
20.3 +_. 2.6% (n = 3) compared to 22.8 + 4% (n = 3) after. 
4. DISCUSSION 
By preventing phosphorylation of the receptor by 
either site.directed mutagenesis to remove this phos- 
pho~lat ion ~ite, or by incubating Xenopus oocytes ex- 
pressing receptors with the kinase inhibitor H-7, en- 
hancement of the GABA current by ethanol no longer 
occurs, suggesting that phosphorylation of this site is 
necessary for ethanol potentiation, Using antisense hy- 
bridization to selectively eliminate subunit expression in 
Xenopus oocytes it has been demonstrated that the pres- 
ence of the 72L subunit is necessary for the action of 
ethanol [23]~ and recent in vitro hybridization studies, 
measuring the distribution of 72S and 7'2L mRNAs 
show higher proportions of ?'2L expression in regions 
of  the brain in which GABAA receptors have been 
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Fig. 3. Modulation of GABA curr~nt~ in oocytes expressing the 
GABAA recel.,i.~r combination of odfli r2L, Potentiation of a 30/aM 
GABA respoIce by I aM flunitrazepam and 20 mM ethanol is shown 
either in untr~.atcd oocytes or tho,~ which have been incubated for 
2-'!, h ia 0 2 mM t-=oquinotinesulphonyl-2-meth.vi pi~razine dihydro- 
chloride (H-7) the protein k;na~ inhibitor, Each bar represents he 
mean :l: S.E M o1" the number ofoocytcs rested as indicated above the 
bars together with the number of different donor frogs. 
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shown sensitive to ethanol, such as cerebellum [29,30]. 
However, in the hippocampus where 72S is more abun- 
dant than 72L, a number of cells are sensitive to ethanol 
[22], while others are not. Insensitivity to ethanol may 
be ,~,~plained by expression of 7,'2S rather than ):2L or 
alternatively the level of phosphorylation/activity of ki- 
nases in these cells may be influencing the sensitivity of 
receptors to ethanol. Xenopus oocytes contain a large 
pool of endogenous phosphate [31] and it is possible 
that there may be a high level of phosphorylation when 
receptors are expressed in these cells. This might ac- 
count for the observation that kinase inhibitors reduce 
the potentiation of GABAA receptors by ethanol but 
increasing the actwity of protein kinase C with PMA 
does not affect the extent of enhancement. However, the 
fact that both PMA and cAMP dependent kinase can 
inhibit the GABA response itself suggests that other 
phosphorylation sites on the receptor are 
phosphorylated to a lesser degree. Other studies have 
also demonstrated that activation of protein kinase C 
[27,32] and cAMP dependent kinase can inhibit native 
GABA responses [33,34]. Recent studies with different 
subunits of the GABAA receptor show that all receptors 
made up of subunits which contain putative phospho- 
rylation sites are inhibited equally by PMA [28]. Other 
evidence that phosphorylation may modulate thanol 
sensitivity of GABAA receptors comes from studies of 
ethanol potentiation i mouse brain cortical microsacs 
where ethanol modulation is reduced with longer tissue 
incubation times whereas benzodiazepine and barbitu- 
rate potentiation are unaffected [36]. Important en- 
zymes are probably lost over longer incubation times 
which can affect the phosphorylation state of the recep- 
tor. Ethanol modulation has also recently been shown 
to be highly sensitive to temperature, again suggesting 
some post-translational modification of the receptor is 
involved [30]. Farther evidence which indicates that an 
enzyme may be involved comes from mouse lines se- 
lected for ethanol sensitivity. Genetically selected mice 
which are sensitive (LS) or insensitive (SS) to ethanol 
sedation have GABA receptors which are correspond- 
ingly sensitive (LS) or insensitive (SS) to potentiation by 
ethanol when whole brain mRNA is expressed in Xen- 
opus oocytes [38]. Studies expressing different ratios of 
LS/SS brain mRNA in .Yenopus oocytes how that SS 
sensitivity dominates, and that a simple mixing of differ- 
ent subunits cannot explain this behaviour [38]. Fur- 
ther, quantitation of subunit mRNA in the two strains 
shows no differences in the amounts or distribution of 
72L or 72S [30]. 
The molecular mechanism by which ethanol potenti- 
ates GABA currents remains unclear. The rapid re- 
sponse makes it unlikely that ethanol itself modulates 
pl:-,,,spb.ory!ation f the receptor, and recent in vitro 
experiments have shown lhat ethanol does not directly 
affect he phosphorylation f GABAA receptor subunits 
[39]. More likely is that phosphorylation f receptors at 
Set 34~ alters the conformation of the receptor. This may 
then allow ethanol to cause its modulatory effect, per- 
haps through a specific binding site which could be 
extracellular, in the lnernbrane spanning region, or in- 
tracellular. 
Protein phosphorylation is an extremely important 
mechanism of receptor modulation and plays a major 
role in cell excitability and neuronal function (reviewed 
in [40]). These processes may be involved in many clin- 
ical disorders affecting signal transduction and brain 
function. We have demonstrated a new role for phos- 
phorylation in the mechanism by which alcohol affects 
the nervous system. Individual differences in enzymes 
which can determine the phosphorylation state of recep- 
tors may explain differences in behavioural sensitivity 
to alcohol, and identification of these enzymes might 
provide new tools to aid in our understanding of the 
genetic basis of alcohol susceptibility and alcoholism. 
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